CAS 1401031-39-7
:6-Oxaspiro[4.5]décane-9-éthanamine, N-[(3-méthoxy-2-thiényl)méthyl]-9-(2-pyridinyl)-, chlorhydrate (1:1), (9R)-
- (9R)-N-[(3-Methoxy-2-thienyl)methyl]-9-(2-pyridinyl)-6-oxaspiro[4.5]decane-9-ethanamine hydrochloride (1:1)
- 6-Oxaspiro[4.5]decane-9-ethanamine, N-[(3-methoxy-2-thienyl)methyl]-9-(2-pyridinyl)-, hydrochloride (1:1), (9R)-
TRV-130 Hydrochloric Acid Salt
CAS :Produit contrôléApplications TRV-130 is a μ-opioid receptor (MOR) G protein-biased ligand. It is potently analgesic while causing less gastrointestinal dysfunction and respiratory suppression than morphine at equianalgesic doses.
References DeWire, S., et al.: J. Pharm. Exper. Ther., 344, 708 (2013); Soergel, D., et al.: Pain, 155, 1829 (2014)Formule :C22H30N2O2S·HClCouleur et forme :NeatMasse moléculaire :423.01TRV-130·HCl
CAS :Produit contrôléTRV-130·HCl is a mu-opioid receptor agonist that has been shown to produce antinociceptive effects in both acute and chronic pain models. It has also been shown to have potential therapeutic benefits in animal models of neuropathic pain, inflammatory pain, and visceral pain. TRV-130·HCl has a high binding affinity for the mu-opioid receptor and can be used as an analgesic drug candidate. This compound produces a profile that is similar to morphine, although it may lack some of the side effects common with this drug. TRV-130·HCl has not yet undergone any clinical trials for human use and there is no information on its safety or efficacy during pregnancy.
Formule :C22H30N2O2S·HClDegré de pureté :Min. 95%Masse moléculaire :423.01 g/molTRV-130·HCl (racemic, 95%+)
CAS :Produit contrôléTRV-130 is a mu-opioid agonist with nociceptive and antinociceptive properties. It has been shown to have a high affinity for the mu-opioid receptor, which is responsible for pain control. TRV-130 has also been found to be effective against inflammatory pain and neuropathic pain in animal models. TRV-130 has been shown to decrease the release of glutamate and substance P in animal models, which are neurotransmitters that play an important role in inflammatory and neuropathic pain. TRV-130 may also be used as a therapeutic strategy for the treatment of chronic pain.Formule :C22H30N2O2S·HClDegré de pureté :Min. 95%Masse moléculaire :423.01 g/mol6-Oxaspiro[4.5]decane-9-ethanamine, N-[(3-methoxy-2-thienyl)methyl]-9-(2-pyridinyl)-, hydrochloride (1:1), (9R)-
CAS :Formule :C22H31ClN2O2SCouleur et forme :SolidMasse moléculaire :423.0117



